Detalhe da pesquisa
1.
Designed nanoparticles elicit cross-reactive antibody responses to conserved influenza virus hemagglutinin stem epitopes.
PLoS Pathog;
19(8): e1011514, 2023 08.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37639457
2.
Commercial influenza vaccines vary in HA-complex structure and in induction of cross-reactive HA antibodies.
Nat Commun;
14(1): 1763, 2023 03 30.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36997521
3.
Corrigendum: Impact of adjuvant: trivalent vaccine with quadrivalent-like protection against heterologous Yamagata-lineage influenza B virus.
Front Immunol;
14: 1283355, 2023.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37771593
4.
Impact of adjuvant: Trivalent vaccine with quadrivalent-like protection against heterologous Yamagata-lineage influenza B virus.
Front Immunol;
13: 1002286, 2022.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36248851
5.
Structural analysis of influenza vaccine virus-like particles reveals a multicomponent organization.
Sci Rep;
8(1): 10342, 2018 07 09.
Artigo
em Inglês
| MEDLINE
| ID: mdl-29985483
6.
Characterization of Hemagglutinin Antigens on Influenza Virus and within Vaccines Using Electron Microscopy.
Vaccines (Basel);
6(2)2018 May 25.
Artigo
em Inglês
| MEDLINE
| ID: mdl-29799445